US Patent No. 9,169,479

Microfluidic device-based nucleic acid purification method
Oct 29, 2015

Rheonix has been awarded US Patent No. 9,169,479, "Microfluidic device-based nucleic acid purification method."

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.